ABCL
Price
$5.84
Change
-$0.33 (-5.35%)
Updated
Oct 9, 03:58 PM (EDT)
Capitalization
1.84B
28 days until earnings call
CING
Price
$4.33
Change
+$0.12 (+2.85%)
Updated
Oct 9, 12:59 PM (EDT)
Capitalization
23.6M
Interact to see
Advertisement

ABCL vs CING

Header iconABCL vs CING Comparison
Open Charts ABCL vs CINGBanner chart's image
AbCellera Biologics
Price$5.84
Change-$0.33 (-5.35%)
Volume$22.54K
Capitalization1.84B
Cingulate
Price$4.33
Change+$0.12 (+2.85%)
Volume$100
Capitalization23.6M
ABCL vs CING Comparison Chart in %
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CING commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and CING is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (ABCL: $6.17 vs. CING: $4.21)
Brand notoriety: ABCL and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 189% vs. CING: 111%
Market capitalization -- ABCL: $1.84B vs. CING: $23.6M
ABCL [@Biotechnology] is valued at $1.84B. CING’s [@Biotechnology] market capitalization is $23.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCING’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CING’s FA Score: 1 green, 4 red.
According to our system of comparison, CING is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while CING’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • CING’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than CING.

Price Growth

ABCL (@Biotechnology) experienced а +3.52% price change this week, while CING (@Biotechnology) price change was +0.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.55%. For the same industry, the average monthly price growth was +21.90%, and the average quarterly price growth was +89.35%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.84B) has a higher market cap than CING($23.6M). ABCL YTD gains are higher at: 110.580 vs. CING (-14.604). CING has higher annual earnings (EBITDA): -17.21M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. CING (8.9M). CING has less debt than ABCL: CING (6.58M) vs ABCL (142M). ABCL has higher revenues than CING: ABCL (32.9M) vs CING (0).
ABCLCINGABCL / CING
Capitalization1.84B23.6M7,814%
EBITDA-197.92M-17.21M1,150%
Gain YTD110.580-14.604-757%
P/E RatioN/A0.03-
Revenue32.9M0-
Total Cash553M8.9M6,213%
Total Debt142M6.58M2,157%
TECHNICAL ANALYSIS
Technical Analysis
ABCLCING
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTLB2.050.65
+46.43%
XTL Biopharmaceuticals Ltd
CTEV57.361.73
+3.11%
Claritev Corporation
VABK38.700.65
+1.71%
Virginia National Bankshares Corp
FERG234.883.87
+1.68%
Ferguson Enterprises Inc.
MAC17.19-0.20
-1.15%
Macerich Company (The)

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with ABCL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+1.45%
ABCL - CING
37%
Loosely correlated
+6.93%
BEIGF - CING
29%
Poorly correlated
N/A
RXRX - CING
29%
Poorly correlated
+16.44%
ELVN - CING
29%
Poorly correlated
+1.04%
SLNO - CING
28%
Poorly correlated
+1.01%
More